NASDAQ:AEMD - Aethlon Medical Stock Price, Price Target & More

$1.29 -0.04 (-3.01 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$1.29
Today's Range$1.28 - $1.38
52-Week Range$0.79 - $3.85
Volume111,015 shs
Average Volume469,342 shs
Market Capitalization$22.55 million
P/E Ratio-1.37
Dividend YieldN/A
Beta2.16

About Aethlon Medical (NASDAQ:AEMD)

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Debt-to-Equity Ratio0.18%
Current Ratio17.03%
Quick Ratio17.03%

Price-To-Earnings

Trailing P/E Ratio-1.37
Forward P/E Ratio-2.69
P/E GrowthN/A

Sales & Book Value

Annual Sales$390,000.00
Price / Sales55.24
Cash FlowN/A
Price / CashN/A
Book Value$0.07 per share
Price / Book18.43

Profitability

EPS (Most Recent Fiscal Year)($0.94)
Net Income$-7,270,000.00
Net MarginsN/A
Return on Equity-569.13%
Return on Assets-265.51%

Miscellaneous

Employees7
Outstanding Shares16,700,000

How to Become a New Pot Stock Millionaire

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How were Aethlon Medical's earnings last quarter?

Aethlon Medical (NASDAQ:AEMD) announced its earnings results on Thursday, February, 1st. The medical equipment provider reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.12) by $0.04. The medical equipment provider earned $0.08 million during the quarter, compared to analysts' expectations of $0.08 million. View Aethlon Medical's Earnings History.

What price target have analysts set for AEMD?

1 analysts have issued 1 year target prices for Aethlon Medical's stock. Their forecasts range from $3.00 to $3.00. On average, they expect Aethlon Medical's share price to reach $3.00 in the next year. View Analyst Ratings for Aethlon Medical.

Who are some of Aethlon Medical's key competitors?

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the folowing people:
  • Mr. James A. Joyce, Founder, CEO, Sec. & Director (Age 56)
  • Mr. Rodney S. Kenley, Pres & Director (Age 68)
  • Mr. James B. Frakes, CFO & Sr. VP of Fin., CHIEF ACCOUNTING OFFICER (Age 61)
  • Dr. Richard H. Tullis, Consultant (Age 73)
  • Dr. Annette Marleau Ph.D., Director of Research (Age 43)

Has Aethlon Medical been receiving favorable news coverage?

News articles about AEMD stock have been trending somewhat negative recently, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aethlon Medical earned a news sentiment score of -0.01 on Accern's scale. They also assigned media stories about the medical equipment provider an impact score of 47.80 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.29.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $22.55 million and generates $390,000.00 in revenue each year. The medical equipment provider earns $-7,270,000.00 in net income (profit) each year or ($0.94) on an earnings per share basis. Aethlon Medical employs 7 workers across the globe.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]


MarketBeat Community Rating for Aethlon Medical (AEMD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aethlon Medical (NASDAQ:AEMD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Aethlon Medical in the last 12 months. Their average twelve-month price target is $3.00, suggesting that the stock has a possible upside of 132.56%. The high price target for AEMD is $3.00 and the low price target for AEMD is $3.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.00$3.00$3.00N/A
Price Target Upside: 132.56% upside209.28% upside209.28% upsideN/A

Aethlon Medical (NASDAQ:AEMD) Consensus Price Target History

Price Target History for Aethlon Medical (NASDAQ:AEMD)

Aethlon Medical (NASDAQ:AEMD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2017HC WainwrightInitiated CoverageBuy -> Buy$3.00N/AView Rating Details
(Data available from 4/20/2016 forward)

Earnings

Aethlon Medical (NASDAQ:AEMD) Earnings History and Estimates Chart

Earnings by Quarter for Aethlon Medical (NASDAQ:AEMD)

Aethlon Medical (NASDAQ:AEMD) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20181($0.09)($0.09)($0.09)

Aethlon Medical (NASDAQ AEMD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/9/2018Q3 2018($0.11)($0.08)$0.08 million$0.08 millionViewListenView Earnings Details
2/1/2018Q3 2018($0.12)($0.08)$0.08 million$0.08 millionViewN/AView Earnings Details
11/2/2017Q2 2018($0.16)($0.14)$0.02 millionViewN/AView Earnings Details
8/10/2017Q1 2018($0.16)($0.21)ViewN/AView Earnings Details
6/28/2017Q4 2017($0.18)($0.22)ViewN/AView Earnings Details
2/10/2017Q3 2017($0.16)($0.15)ViewN/AView Earnings Details
11/10/2016Q217($0.15)($0.29)$0.20 million$0.39 millionViewN/AView Earnings Details
8/11/2016Q117($0.20)($0.28)$192.50 million$4.64 millionViewListenView Earnings Details
6/29/2016Q4 2016($0.20)($0.16)$0.27 million$0.21 millionViewN/AView Earnings Details
2/4/2016Q316($0.17)($0.16)$0.33 million$0.30 millionViewN/AView Earnings Details
11/16/2015Q216($0.17)($0.16)$0.20 million$0.19 millionViewN/AView Earnings Details
8/13/2015Q116($0.18)($0.18)$0.19 million$0.19 millionViewN/AView Earnings Details
2/10/2015Q3 2015($0.50)$0.18 million$0.03 millionViewN/AView Earnings Details
8/14/2014Q1 2015($1.00)$0.26 million$0.05 millionViewN/AView Earnings Details
2/11/2014Q3 2014($0.50)$0.52 million$0.08 millionViewN/AView Earnings Details
6/29/2012Q4 2012($2.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Aethlon Medical (NASDAQ:AEMD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Aethlon Medical (NASDAQ AEMD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.58%
Institutional Ownership Percentage: 5.14%
Insider Trading History for Aethlon Medical (NASDAQ:AEMD)
Institutional Ownership by Quarter for Aethlon Medical (NASDAQ:AEMD)

Aethlon Medical (NASDAQ AEMD) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Aethlon Medical (NASDAQ AEMD) News Headlines

Source:
DateHeadline
ValuEngine Downgrades Aethlon Medical (AEMD) to Strong SellValuEngine Downgrades Aethlon Medical (AEMD) to Strong Sell
www.americanbankingnews.com - April 7 at 3:19 PM
Aethlon Medical (AEMD) Upgraded to "Hold" by ValuEngineAethlon Medical (AEMD) Upgraded to "Hold" by ValuEngine
www.americanbankingnews.com - April 3 at 8:11 PM
BRIEF-Aethlon Medical Participates In Informational Meeting With FDABRIEF-Aethlon Medical Participates In Informational Meeting With FDA
www.reuters.com - March 22 at 9:50 AM
Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in PhoenixStudy of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix
finance.yahoo.com - March 22 at 9:50 AM
Aethlon Medical To Present at the American Society for Microbiology Biothreats MeetingAethlon Medical To Present at the American Society for Microbiology Biothreats Meeting
finance.yahoo.com - February 12 at 9:00 AM
Aethlon Medical, Inc. (AEMD) Forecasted to Post FY2018 Earnings of ($0.48) Per ShareAethlon Medical, Inc. (AEMD) Forecasted to Post FY2018 Earnings of ($0.48) Per Share
www.americanbankingnews.com - February 8 at 2:04 PM
AEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA MindsetAEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA Mindset
finance.yahoo.com - February 6 at 4:30 PM
Aethlon Medical (AEMD) Posts  Earnings Results, Beats Estimates By $0.03 EPSAethlon Medical (AEMD) Posts Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - February 2 at 10:40 AM
Aethlon Medical Announces Fiscal 2018 Third Quarter ResultsAethlon Medical Announces Fiscal 2018 Third Quarter Results
finance.yahoo.com - February 1 at 4:31 PM
Aethlon Medical (AEMD) to Release Earnings on ThursdayAethlon Medical (AEMD) to Release Earnings on Thursday
www.americanbankingnews.com - February 1 at 1:22 AM
Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018
finance.yahoo.com - January 29 at 9:09 AM
Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying ExosomesAethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes
finance.yahoo.com - January 23 at 8:26 AM
Is It The Right Time To Buy Aethlon Medical Inc (NASDAQ:AEMD)?Is It The Right Time To Buy Aethlon Medical Inc (NASDAQ:AEMD)?
finance.yahoo.com - January 22 at 5:44 PM
Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral InfectionsAethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections
finance.yahoo.com - January 18 at 7:10 PM
Sabrina Martucci Johnson Joins Aethlon Medicals Board of DirectorsSabrina Martucci Johnson Joins Aethlon Medical's Board of Directors
finance.yahoo.com - January 10 at 11:09 AM
Aethlon Shares Jump Before 60 Minutes Report On CTE, VetsAethlon Shares Jump Before '60 Minutes' Report On CTE, Vets
finance.yahoo.com - January 7 at 11:32 PM
How Does Aethlon Medical Inc’s (NASDAQ:AEMD) Earnings Growth Stack Up Against Industry Performance?How Does Aethlon Medical Inc’s (NASDAQ:AEMD) Earnings Growth Stack Up Against Industry Performance?
finance.yahoo.com - December 27 at 8:57 PM
What Investors Should Know About Aethlon Medical Inc’s (AEMD) Financial StrengthWhat Investors Should Know About Aethlon Medical Inc’s (AEMD) Financial Strength
finance.yahoo.com - November 21 at 4:07 PM
Aethlon Medical, Inc. (AEMD) Earns Buy Rating from Analysts at HC WainwrightAethlon Medical, Inc. (AEMD) Earns Buy Rating from Analysts at HC Wainwright
www.americanbankingnews.com - November 20 at 8:16 PM
FY2018 Earnings Forecast for Aethlon Medical, Inc. (AEMD) Issued By Zacks Investment ResearchFY2018 Earnings Forecast for Aethlon Medical, Inc. (AEMD) Issued By Zacks Investment Research
www.americanbankingnews.com - November 14 at 10:23 PM

SEC Filings

Aethlon Medical (NASDAQ:AEMD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Aethlon Medical (NASDAQ:AEMD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Aethlon Medical (NASDAQ AEMD) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.